Exelixis Inc. [NASDAQ: EXEL] gained 2.98% on the last trading session, reaching $17.97 price per share at the time. The company report on August 6, 2021 that Exelixis Announces Second Quarter 2021 Financial Results and Provides Corporate Update.
– Total Revenues of $385.2 Million, Cabozantinib Franchise Revenues of $284.2 Million -.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
– GAAP Diluted EPS of $0.30, Non-GAAP Diluted EPS of $0.37 -.
Exelixis Inc. represents 312.47 million in outstanding shares, while the company has a total market value of $5.55 billion with the latest information. EXEL stock price has been found in the range of $17.46 to $17.98.
If compared to the average trading volume of 2.32M shares, EXEL reached a trading volume of 2103360 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Exelixis Inc. [EXEL]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for EXEL shares is $29.93 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on EXEL stock is a recommendation set at 1.90. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for Exelixis Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on August 06, 2021. While these analysts kept the previous recommendation, H.C. Wainwright raised their target price to Buy. The new note on the price target was released on June 15, 2021, representing the official price target for Exelixis Inc. stock. Previously, the target price had yet another raise to $23, while Goldman analysts kept a Sell rating on EXEL stock.
The Average True Range (ATR) for Exelixis Inc. is set at 0.57, with the Price to Sales ratio for EXEL stock in the period of the last 12 months amounting to 5.38. The Price to Book ratio for the last quarter was 2.94, with the Price to Cash per share for the same quarter was set at 3.84. Price to Free Cash Flow for EXEL in the course of the last twelve months was 31.06 with Quick ratio for the last quarter at 6.60.
Trading performance analysis for EXEL stock
Exelixis Inc. [EXEL] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 5.71. With this latest performance, EXEL shares gained by 2.74% in over the last four-week period, additionally sinking by -18.58% over the last 6 months – not to mention a drop of -17.80% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for EXEL stock in for the last two-week period is set at 52.71, with the RSI for the last a single of trading hit 62.40, and the three-weeks RSI is set at 47.16 for Exelixis Inc. [EXEL]. The present Moving Average for the last 50 days of trading for this stock 19.16, while it was recorded at 17.49 for the last single week of trading, and 21.44 for the last 200 days.
Exelixis Inc. [EXEL]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Exelixis Inc. [EXEL] shares currently have an operating margin of +11.14 and a Gross Margin at +96.33. Exelixis Inc.’s Net Margin is presently recorded at +11.32.
Return on Total Capital for EXEL is now 6.00, given the latest momentum, and Return on Invested Capital for the company is 6.10. Return on Equity for this stock inclined to 6.27, with Return on Assets sitting at 5.53. When it comes to the capital structure of this company, Exelixis Inc. [EXEL] has a Total Debt to Total Equity ratio set at 2.77. Additionally, EXEL Total Debt to Total Capital is recorded at 2.70, with Total Debt to Total Assets ending up at 2.43. Long-Term Debt to Equity for the company is recorded at 2.61, with the Long-Term Debt to Total Capital now at 2.54.
Reflecting on the efficiency of the workforce at the company, Exelixis Inc. [EXEL] managed to generate an average of $144,607 per employee. Receivables Turnover for the company is 6.92 with a Total Asset Turnover recorded at a value of 0.49.Exelixis Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 6.60 and a Current Ratio set at 6.70.
An analysis of insider ownership at Exelixis Inc. [EXEL]
There are presently around $4,808 million, or 85.40% of EXEL stock, in the hands of institutional investors. The top three institutional holders of EXEL stocks are: BLACKROCK INC. with ownership of 31,294,943, which is approximately -2.539% of the company’s market cap and around 1.70% of the total institutional ownership; VANGUARD GROUP INC, holding 29,400,178 shares of the stock with an approximate value of $528.32 million in EXEL stocks shares; and PRICE T ROWE ASSOCIATES INC /MD/, currently with $372.6 million in EXEL stock with ownership of nearly 17.886% of the company’s market capitalization.
Positions in Exelixis Inc. stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 151 institutional holders increased their position in Exelixis Inc. [NASDAQ:EXEL] by around 24,716,952 shares. Additionally, 181 investors decreased positions by around 19,825,195 shares, while 59 investors held positions by with 223,006,093 shares. The mentioned changes placed institutional holdings at 267,548,240 shares, according to the latest SEC report filing. EXEL stock had 46 new institutional investments in for a total of 2,517,418 shares, while 48 institutional investors sold positions of 2,745,658 shares during the same period.